Navigation Links
Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
Date:10/7/2009

ence clinical trials, which is an important milestone to validate its efficacy. We anticipate Zushima will drive incremental revenue growth in 2010 and beyond," said Mr. Wang Ronghua, Chairman and CEO of Biostar Pharmaceuticals, Inc. "Developing new products with high revenue potential will continue to be a key component of our long-term strategy. We expect to immediately launch the Zushima spray in both military and civil markets after the final approval is received in 2010."

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary in China, develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based OTC products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for two patents.

Safe Harbor

Certain statements in this release concerning our future growth prospects are forward-looking statements, within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to sustain our previous levels of profitability including on account of our ability to manage growth, intense compe
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
7. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
8. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
9. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
10. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
11. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015  Genoa has acquired West Bend Assisted Living ... pharmacy location with a proven track record for excellent ... settings, and those involved in their care. Both companies ... delivering true value to their customers. ... of pharmacy services dedicated to the behavioral health community ...
(Date:7/1/2015)... July 1, 2015 Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and marketing ... Radie , president and chief executive officer, is ... He will provide an update on Egalet,s marketed ... Nasal Spray, approved product OXAYDO ™ (oxycodone ...
(Date:7/1/2015)... FRANCISCO , July 1, 2015 ... market) is expected to reach USD 49,119.2 million by ... Research, Inc. Monitoring services is expected to remain the ... of USD 1,227.5 million in 2012, and an estimated ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , Browse ...
Breaking Medicine Technology:Genoa, a QoL Healthcare Company Acquires West Bend Assisted Living Pharmacy 2Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5
... announced today that it has licensed technology from Yale University ... in the January issue of the journal Cell Cycle ... associated with breast cancer risk, such mutations in BRCA1 ... The research identified microRNA disrupting variants in and around ...
... N.J., Feb. 24, 2011 University Radiology Group, ... teleradiology services, is working with MedInformatix Inc. to ... to achieve Stage 1 meaningful use ... Reinvestment Act (ARRA) for Health Information Technology. ...
Cached Medicine Technology:Mira Dx Licenses Triple Negative Breast Cancer Risk Variant from Yale University 2University Radiology Group Works With MedInformatix to Meet Stage 1 Meaningful Use Qualifications 2University Radiology Group Works With MedInformatix to Meet Stage 1 Meaningful Use Qualifications 3
(Date:7/1/2015)... , ... July 01, 2015 , ... ... forms, such as organically raised chickens and eggs. Eating organic foods and products ... is cleaner and more environmentally friendly than production chicken farming. Choosing home raised ...
(Date:7/1/2015)... ... July 01, 2015 , ... Renowned rhinoplasty surgeon and ... 2016 Dallas Rhinoplasty Symposium . Set for March 6th - 8th, the 2016 ... participants from the basic training and fundamentals of nasal surgery through the most modern ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Did you know ... is Men’s Health Month, and we at Advanced Fertility Center of Texas (AFCT) would ... men. , While infertility is often considered to be a “woman’s issue,” male ...
(Date:7/1/2015)... ... July 01, 2015 , ... Convoy of Hope ... in the Twin Cities on Saturday, August 1, at Spring Lake Park High School. ... provide more than $1 million worth of goods and services including free food, health ...
(Date:7/1/2015)... ... July 01, 2015 , ... Scoliosis is a disorder in which the normally straight ... it affects 2 to 3 percent of the population, or an estimated 6 to 9 ... in children between the ages of 10 and 15. Most types of scoliosis are more ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4
... Delayed Diagnosis;,Almost Seventy Percent Report Unnecessary or Duplicative Scans , ... ... released today (at RSNA ) uncovers a host of systemic ... demand and negatively impacting patient diagnosis and care. Of those surveyed, ...
... Corporation ("Bally"),today announced that it has filed for voluntary ... filed today in the U.S. Bankruptcy,Court for the Southern ... the chapter,11 process to significantly reduce debt from its ... It expects to accomplish,these goals through either a sale ...
... Company (PRC),the leading manufacturer of Alternative and Augmented ... selected Acapela High,Quality voices to speech empower Vantage(TM) ... Smart, compact, rugged ... device for children and adults who use augmentative,communication. ...
... Decision Resources, one of the,world,s leading research ... finds that the diagnosis and drug treatment of ... remain low through 2012,particularly in rural regions. Although ... 70 percent of the prevalent Alzheimer,s disease,population in ...
... devoted to injury prevention through exercise, has created the first of its ... DVD, hosted by physical therapist Chantal Donnelly, is distributed by the lifestyle ... Relief DVD is perfect for the gift giving season. , ... Los ...
... availability of their trusted point-of-care information on the iPhone and ... ... (PRWEB) December 3, 2008 -- Lexi-Comp, Inc., a provider of ... iPhone and the iPod touch. This latest innovation enhances Lexi-Comp,s ...
Cached Medicine News:Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 2Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 3Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 4Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 2Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 3Health News:Accessibility: Acapela Group Voice Enables Vantage Lite Innovative AAC Dedicated Device 2Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 2Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 3Health News:New Strong Knees DVD Offers Knee Pain Relief from Body Insight, Inc. and Gaiam Inc. 2Health News:Lexi-Comp Databases Now Available for the iPhone™ and iPod touch 2Health News:Lexi-Comp Databases Now Available for the iPhone™ and iPod touch 3
Porous foundation 440 series....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The Biopro optima stem is manufactured from cobalt chrome and is available in a Non-Porous coat option....
The cemented hip joint prosthesis system....
Medicine Products: